Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of β-arrestin2 and NLRP3

J Zhu, Z Hu, X Han, D Wang, Q Jiang, J Ding… - Cell Death & …, 2018 - nature.com
Astrocytes are involved in the neuroinflammation of neurodegenerative diseases, such as
Parkinson's disease (PD). Among the numerous inflammatory cytokines, interleukin-1β (IL …

Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson's disease model via a β-arrestin2-biased mechanism

J Zhu, T Sun, J Zhang, Y Liu, D Wang, H Zhu… - Brain, Behavior, and …, 2020 - Elsevier
Activated astrocytes secrete inflammatory cytokines such as interleukin-1β (IL-1β) into the
extracellular milieu, damaging surrounding neurons and involving in the pathogenesis of …

Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome

Y Yan, W Jiang, L Liu, X Wang, C Ding, Z Tian, R Zhou - Cell, 2015 - cell.com
Inflammasomes are involved in diverse inflammatory diseases, so the activation of
inflammasomes needs to be tightly controlled to prevent excessive inflammation. However …

The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases

E Possemato, L La Barbera, A Nobili, P Krashia… - Ageing research …, 2023 - Elsevier
Abstract In the Central Nervous System (CNS), neuroinflammation orchestrated by microglia
and astrocytes is an innate immune response to counteract stressful and dangerous insults …

Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice

T Wang, D Nowrangi, L Yu, T Lu, J Tang, B Han… - Journal of …, 2018 - Springer
Background Inflammasomes are involved in diverse inflammatory diseases. Previous study
reported that the neurotransmitter dopamine inhibited NLRP3 inflammasome activation via …

Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson's disease

AF Pike, F Longhena, G Faustini, JM Van Eik… - Journal of …, 2022 - Springer
Background Parkinson's disease (PD) is characterized by the loss of nigral dopaminergic
neurons leading to impaired striatal dopamine signaling, α-synuclein-(α-syn-) rich …

p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease

J Chen, K Mao, H Yu, Y Wen, H She, H Zhang… - Journal of …, 2021 - Springer
Background Parkinson's disease (PD) is characterized by degeneration of dopaminergic
neurons in the substantia nigra pars compacta (SNpc), accompanied by accumulation of α …

Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease

C Qiao, Q Zhang, Q Jiang, T Zhang, M Chen… - Journal of …, 2018 - Springer
Background Parkinson's disease (PD) is a neurodegenerative disorder with progressive loss
of dopaminergic (DA) neurons. Systemic inflammation is shown to initiate and exacerbate …

Microglial NLRP3 inflammasome activates neurotoxic astrocytes in depression-like mice

S Li, Y Fang, Y Zhang, M Song, X Zhang, X Ding… - Cell reports, 2022 - cell.com
The function and regulation of different heterogeneous reactive states of astrocytes in
depression remain unclear. Here, we demonstrate that neurotoxic reactive (A1-like) …

Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation

A Montoya, D Elgueta, J Campos, O Chovar… - Journal of …, 2019 - Springer
Background Neuroinflammation constitutes a pathogenic process leading to
neurodegeneration in several disorders, including Alzheimer's disease, Parkinson's disease …